Pharmacists urge caution on weight loss drug

Pharmacists have been urged to sell the weight loss drug alli only to patients who have undergone a consultation and have a BMI of 28 or higher.

The call from the Royal Pharmaceutical Society of Great Britain (RPSGB) comes after two Sunday newspapers reported cases of pharmacies not complying with regulations around the sale of the drug.

David Pruce, director of policy at the RPSGB, said: ‘Both the society and GSK, which manufactures orlistat, developed and disseminated guidance and training resources for pharmacists in anticipation of the medicine’s launch.

‘It is disappointing that some pharmacies have not followed the guidance. It is important to emphasise the need to closely follow the requirements for selling orlistat.’

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in